OSR Health, Inc.
- Close
- Oct 15, 2026 · +5.26%
- Market cap
- $7.02M
- 35.12M shares
- Filings
- 228
Q3 2026−17.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derived
—Q3 2026N/M FY25 yoy
Q3 2026+397.8% FY25 yoy
- $7.02M
- —
- 4.1×
- 0.1×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Oct 15, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,905,805 | reported | |
| FY 2024 | 2024-12-31 | $3,530,303 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $36.23M | $36.23M | — | 19.28M sh | +242.8% | — |
| FY2023 | — | $36.00M | $36.00M | — | 5.62M sh | −37.9% | — |
Surgical & medical instruments & apparatus
OSR Health, Inc. is the 100th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
LUCDLucid Diagnostics Inc.$4.7M8.3%1,232.7%$86.4MINBSIntelligent Bio Solutions Inc.$4.2M38.1%294.9%$6.4MTNONTenon Medical, Inc.$3.9M20.4%318.4%$1.2MICCMIceCure Medical Ltd.$3.4M2.7%445.6%$51.9MAURXNuo Therapeutics, Inc.$3.3M142.7%75.8%$63.1M
OSRHOSR Health, Inc. (this company)$2.9M17.7%931.2%$7.0M
USAQQHSLab, Inc.$2.7M26.3%17.0%$11.6MFEMYFemasys Inc$2.3M40.8%812.3%$12.3MVYCOVycor Medical Inc$1.9M17.2%3.9%$3.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
OSR Health, Inc. · CIK 1840425 · Engraved from SEC EDGAR